Jon Cuthbert

A 14.175 billion-token World Liberty Financial (CRYPTO:WLFI) allocation matching Donald Trump's disclosed stake has entered a vesting contract.

Reserve Bank of Australia Assistant Governor Sarah Hunter warned that crude oil reaching US$102 a barrel increases inflation risks above the target range of 2% to 3%.

Biofrontera (NASDAQ:BFRI) received U.S. FDA approval of a supplemental New Drug Application for its Ameluz 10% topical gel and BF-RhodoLED lamp to treat adult patients with superficial basal cell carcinoma.

Pasithea Therapeutics (NASDAQ:KTTA) announced that it will present initial clinical data from Part A of its ongoing Phase 1/1b trial evaluating PAS-004 in adults with neurofibromatosis type 1 (NF1).

Hub Group (NASDAQ:HUBG) released preliminary unaudited first-half 2026 results, warning investors that the company expects to report an operating loss before one-time charges due to increased operating pressures and accounting-related expenses.

Radiopharm Theranostics (NASDAQ:RADX) reported that RAD101 PET achieved 93% concordance with MRI across all evaluable lesions in an interim Phase 2b analysis, meeting the imaging trial’s primary endpoint.

BioNTech (NASDAQ:BNTX) and OncoC4 reported updated Phase 3 PRESERVE-003 data showing median overall survival of 18.5 months with gotistobart versus 10.0 months with docetaxel in previously treated squamous NSCLC.

Nanobiotix (NASDAQ:NBTX) reported complete Phase 1 full-cohort results for radiotherapy-activated JNJ-1900, formerly NBTXR3, in 24 patients with inoperable, locoregionally recurrent non-small cell lung cancer eligible for re-irradiation.

OneSteel Manufacturing will reduce its Whyalla steelworks workforce from 1,700 to 1,200 following the permanent shutdown of an unrepairable blast furnace.

Entropy Neurodynamics (ASX:ENP) reported positive Phase 2 trial results for its intravenous psilocin drug TRP-8803.